1-3 of 3
L Reich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.

Free
C H Moskowitz, J R Glassman, D Wuest, P Maslak, L Reich, A Gucciardo, N Coady-Lyons, A D Zelenetz, S D Nimer
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (2): 311–316.
Published: 01 February 1998
View articletitled, Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.
Open the PDF for Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma. in another window
Journal Articles

Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.

Free
F Shapiro, T J Yao, C Moskowitz, L Reich, D L Wuest, S Heimfeld, I K McNiece, J Gabrilove, S Nimer, M A Moore
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (9): 1571–1578.
Published: 01 September 1997
View articletitled, Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.
Open the PDF for Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells. in another window
Journal Articles

Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer.

Free
L Vahdat, G Raptis, D Fennelly, N Hamilton, L Reich, A Tiersten, M Harrison, C Hudis, M Moore, T J Yao, Larry Norton, John Crown
Journal: Clinical Cancer Research
Clin Cancer Res (1995) 1 (11): 1267–1273.
Published: 01 November 1995
View articletitled, Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer.
Open the PDF for Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer. in another window